Search

everythinglearnresearchcommunity

for

Search:↓

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Many men misuse oral contraceptive pills for things like hair growth and muscle gain.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Certain genes affect udder shape in Holstein cows, important for health and milk production.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

The document explains how male reproductive hormones work and affect the body.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Lower SHBG levels may increase the risk of PCOS.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.